Investment
Features
FeesSafety
Academy
More
Pluang+

Robotic endoscopy devices market to grow at 10% CAGR, reaching $6.5B by 2034 driven by tech advances and rising GI disorders.

Market News
22 Jul 2026
Delveinsight
View Source
Bullish
pluang ai news

The global robotic endoscopy devices market is projected to grow at a compound annual growth rate (CAGR) of about 10% from 2026 to 2034, reaching an estimated value of $6.5 billion by 2034. This growth is fueled by increasing demand for minimally invasive procedures, rising prevalence of gastrointestinal disorders and colorectal cancer, and continuous technological advancements such as AI-enabled navigation and enhanced imaging. North America currently leads the market, supported by strong healthcare infrastructure and regulatory approvals, while Asia-Pacific is expected to experience the fastest growth due to expanding healthcare access and aging populations. Key players include Intuitive Surgical, Johnson & Johnson MedTech, Medtronic, and Olympus Corporation, among others.

More News (ISRG)

Global indocyanine green market to grow to $380M by 2031, driven by surgical imaging advances.

Global indocyanine green market to grow to $380M by 2031, driven by surgical imaging advances.

The global indocyanine green (ICG) market, valued at $180 million in 2025, is projected to reach $380 million by 2031 with a CAGR of 13.26%. Growth is fueled by rising adoption of ICG-based fluorescence imaging in minimally invasive and robotic surge...

Market News
Bullish
7 hours ago
Nightview Capital shifts portfolio, sees AI fears in software as overblown, buys gaming and hospitality stocks.

Nightview Capital shifts portfolio, sees AI fears in software as overblown, buys gaming and hospitality stocks.

Nightview Capital exited Meta, Intuitive Surgical, Shopify, and EchoStar, while increasing stakes in Las Vegas Sands, MGM Resorts, and Wynn Resorts, focusing on gaming and hospitality. They argue the market overreacted to AI risks in software, believ...

Market News
Neutral
14 hours ago
Intuitive Surgical shares drop 38% amid U.S. procedure slowdowns and valuation concerns

Intuitive Surgical shares drop 38% amid U.S. procedure slowdowns and valuation concerns

Intuitive Surgical's stock has fallen about 38% due to concerns over valuation and slowing U.S. procedure growth, despite strong Q2 2026 earnings and raised guidance. The decline is linked to expiring ACA subsidies affecting elective surgeries and re...

Company Fundamentals
Bullish
2 days ago
Intuitive Surgical stays a buy despite nearly 30% stock drop, with strong margins and growth outlook.

Intuitive Surgical stays a buy despite nearly 30% stock drop, with strong margins and growth outlook.

Intuitive Surgical's stock has fallen nearly 30%, but the company remains a buy due to resilient adoption metrics and strong growth in system placements and installed base. Despite softer U.S. procedure growth, profitability improved with Q2 non-GAAP...

Analyst Insights
Bullish
4 days ago
Key stocks including Intuitive Surgical drop sharply on growth and dilution concerns

Key stocks including Intuitive Surgical drop sharply on growth and dilution concerns

Several key stocks fell significantly due to company-specific issues. Intuitive Surgical's shares dropped 14.15% despite strong earnings because of slower growth in surgical procedures, impacting related leveraged ETFs. REGENXBIO's stock fell 11.7% a...

Market News
Bearish
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App